Source: Pharmacy Times articles
Adherence to GLP-1 receptor agonists showed a 59% drop in inpatient hospital costs.
Read More
Recent Content
- Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
- Navigating Lymphoma and Survivorship in Adolescents and Young Adults
- EMERALD Trial Results: What Prior CDK4/6i Duration Means for Treatment Success
- Managing Elacestrant Treatment: From Patient Selection to Supportive Care
- Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review
- Expert: Navigating the Next Decade of Market Growth and Innovation for Biosimilars
- Honoring a Healer: Personal Care With National Impact
- Breaking Barriers: Why Increasing Lung Screening is Critical
- GLP-1 Drugs Show Promise in Lowering Health Care Costs, Report Says
- Asembia AXS25: Emotional Support Transforms Specialty Pharmacy Patient Care